P495: UNLOCKING THE POTENTIAL OF SYNTHETIC PATIENTS FOR ACCELERATING CLINICAL TRIALS: RESULTS OF THE FIRST GIMEMA EXPERIENCE

• Alfonso Piciocchi,
• Marta Cipriani,
• Monica Messina,
• Giovanni Marconi,
• Valentina Arena,
• Stefano Soddu,
• Enrico Crea,
• Maria Valeria Feraco,
• Marco Ferrante,
• Edoardo la Sala,
• Paola Fazi,
• Francesco Buccisano,
• Giovanni Martinelli,
• Adriano Venditti,
• Marco Vignetti

Affiliations

Alfonso Piciocchi

1 GIMEMA Foundation, Rome, Italy

Marta Cipriani

1 GIMEMA Foundation, Rome, Italy

Monica Messina

1 GIMEMA Foundation, Rome, Italy

Giovanni Marconi

3 Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) “Dino Amadori”, Meldola, Italy

Valentina Arena

1 GIMEMA Foundation, Rome, Italy

Stefano Soddu

1 GIMEMA Foundation, Rome, Italy

Enrico Crea

1 GIMEMA Foundation, Rome, Italy

Maria Valeria Feraco

4 Studio Legale FLC, Rome, Italy

Marco Ferrante

4 Studio Legale FLC, Rome, Italy

Edoardo la Sala

1 GIMEMA Foundation, Rome, Italy

Paola Fazi

1 GIMEMA Foundation, Rome, Italy

Francesco Buccisano

5 Division of Hematology, Tor Vergata Foundation Polyclinic, Rome, Italy; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy

Giovanni Martinelli

6 IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Rome, Italy

Adriano Venditti

5 Division of Hematology, Tor Vergata Foundation Polyclinic, Rome, Italy; Hematology, Department of Biomedicine e Prevention, Tor Vergata University, Rome, Italy

Marco Vignetti

1 GIMEMA Foundation, Rome, Italy